Literature DB >> 30962070

Sterile keratitis following standard corneal collagen crosslinking: A case series and literature review.

D Mereaux1, J Knoeri1, L Jouve1, L Laroche2, V Borderie2, N Bouheraoua3.   

Abstract

Standard corneal collagen crosslinking (S-CXL) is a safe, approved procedure, but it may result in severe pain, early vision loss and possible complications, such as infectious or sterile keratitis, in some cases. We describe four cases of sterile infiltrates after uneventful S-CXL for keratoconus, from diagnosis to medical management with six months of follow-up, reporting their pathophysiological features, and comparing our findings with published reports. We discuss various possibilities for diagnosing sterile infiltration more rapidly. In terms of the pathophysiology of sterile infiltrate formation, we separated our patients into two types, one with sterile infiltrate from an antigen reaction and the other with sterile infiltrate due to excessive scarring. Early local steroid treatment resulted in a good visual outcome in our cases.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Complication; Cornea; Cornée; Crosslinking; Keratoconus; Kératite stérile; Kératocône; Réticulation; Sterile keratitis

Year:  2019        PMID: 30962070     DOI: 10.1016/j.jfo.2018.11.015

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  3 in total

1.  Infectious keratitis after corneal crosslinking: systematic review.

Authors:  Caroline E Murchison; W Matthew Petroll; Danielle M Robertson
Journal:  J Cataract Refract Surg       Date:  2021-08-01       Impact factor: 3.528

2.  Sterile Corneal Infiltrate Management After Corneal Crosslinking in Pediatric Keratoconus.

Authors:  Ayhan Saglik; Mehmed Ugur Isik
Journal:  Beyoglu Eye J       Date:  2020-02-17

3.  Retrospective Analysis of Sterile Corneal Infiltrates in Patients with Keratoconus after Cross-Linking Procedure.

Authors:  Magdalena Krok; Ewa Wróblewska-Czajka; Joanna Kokot; Anna Micińska; Edward Wylęgała; Dariusz Dobrowolski
Journal:  J Clin Med       Date:  2022-01-25       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.